Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.162
-0.008 (-0.37%)
At close: Sep 25, 2026, 4:00 PM EDT
2.140
-0.022 (-1.02%)
Pre-market: Sep 28, 2026, 7:28 AM EDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $4.8 million as of September 25, 2026. Its market cap has decreased by -66.17% in one year.
Market Cap
4.80M
Enterprise Value
-2.04M
1-Year Change
-66.17%
Ranking
Category
Stock Price
$2.16
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $4.80M, a decrease of -74.05%. That is a compound annual growth rate of -7.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.80M | -80.53% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 5.71M |
| NuCana | 5.60M |
| Ernexa Therapeutics | 5.60M |
| Xenetic Biosciences | 5.58M |
| Lexaria Bioscience | 5.25M |
| PharmaCyte Biotech | 4.83M |
| Dermata Therapeutics | 4.63M |
| GRI Bio | 4.46M |